HIF1A and Parkinson disease: Nevertheless, the neuroprotective function of HO-1 appears to be closely associated with both the Nrf2 and HIF-1 pathways, highlighting the potential of targeting the Nrf2/HO-1 and HIF-1/HO-1 pathways for PD therapy.